sanuwave
-
Financial
SANUWAVE Business Update
Estimated May Revenue Increase of 96% Year Over Year Sales Funnel Increases 5% and System Trials Increases 2% Month Over…
Read More » -
Biologics
SANUWAVE Announces New Board Leadership
SUWANEE, GA, April 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products,…
Read More » -
Financial
SANUWAVE® Business Update
Sales Funnel and System Trials Increase 13% Month Over MonthLaunches Entry into Two New Vertical Markets; Initial Orders Exceed $1…
Read More » -
Financial
SANUWAVE Health Reports Increased Reimbursement Payments for UltraMist and dermaPACE in 2021
SUWANEE, GA, Dec. 23, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a…
Read More » -
Financial
SANUWAVE Health Reports Third Quarter 2020 Financial Results
SUWANEE, GA, Nov. 17, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a…
Read More » -
Biologics
SANUWAVE Health Enters Into Exclusive Letter of Intent to Acquire Celularity’s UltraMIST® and Exclusive Partnership Rights for Wound Care Biologic Products
SUWANEE, GA, June 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that it has entered into…
Read More » -
Biologics
SANUWAVE Health to Deliver dermaPACE® to Patients in the Home Setting
SUWANEE, GA, May 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce they will be…
Read More » -
Financial
SANUWAVE Health Reports Third Quarter 2019 Financial Results
SUWANEE, Ga., Nov. 15, 2019 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended…
Read More » -
Extremities
SANUWAVE Signs Agreement for dermaPACE® System Joint Venture in Brazil
SUWANEE, GA, Nov. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has…
Read More » -
Biologics
SANUWAVE Announces AMBIENSYS SRL as Distributor for dermaPACE® in Romania
SUWANEE, GA, May 09, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has appointed AMBIENSYS…
Read More » -
Biologics
SANUWAVE Will Have Four Podium Presentations as New Clinical Research at EWMA in Poland in May 2018
SUWANEE, GA, March 27, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that during its…
Read More » -
Biologics
DermaPace Technology Suggests Promising Outcomes of Acoustic Pressure Shockwave Treatment for Venous Leg Ulcers (VLU)
SUWANEE, GA, March 08, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development…
Read More » -
Biologics
SANUWAVE Signs $1 Million Equipment Financing Line With NFS Leasing
SUWANEE, GA, Feb. 12, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the Company has signed…
Read More » -
Biologics
SANUWAVE Announces Exhibition at Wounds Canada 2018 Spring Conference
SUWANEE, GA, Feb. 07, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit…
Read More » -
Hospitals
Sanuwave Receives FDA De Novo Decision to Immediately Market the Dermapace System for the Treatment of Diabetic Foot Ulcers in the U.S.
SUWANEE, GA, Jan. 02, 2018 (GLOBE NEWSWIRE) — SANUWAVE Health, Inc. (OTCQB: SNWV) has announced that the U.S. Food and Drug Administration…
Read More »